Loading…
How to read the money
Income and expense are whole-filing amounts associated with this lobbyist, not personal compensation or an allocated share.
No topic inference: each bill number appears in source LDA issue text assigned to this lobbyist.
Caroline Pryce Walker Conquer Childhood Cancer Reauthorization Act
Client: CHILDREN'S CANCER CAUSE · Firm: CHILDREN'S CANCER CAUSE
Childhood Cancer Research, NCI appropriations, Caroline Pryce Walker Conquer Childhood Cancer Reauthorization Act (H.R.2607/S.1251)
Caroline Pryce Walker Conquer Childhood Cancer Reauthorization Act
Client: CHILDREN'S CANCER CAUSE · Firm: CHILDREN'S CANCER CAUSE
Childhood Cancer research, NCI appropriations, Caroline Pryce Walker Conquer Childhood Cancer Reauthorization Act (H.R.2607/S.1251)
Specific issues are shown only where the LDA source assigned them to this lobbyist. Targets apply to the associated filing.
CHILDREN'S CANCER CAUSE via CHILDREN'S CANCER CAUSE
2014 · third_quarter · Q3
Childhood Cancer Research, NCI appropriations, Caroline Pryce Walker Conquer Childhood Cancer Reauthorization Act (H.R.2607/S.1251)
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
CHILDREN'S CANCER CAUSE via CHILDREN'S CANCER CAUSE
2014 · second_quarter · 2A
Source: Senate LDA
Caroline Pryce Walker Conquer Childhood Cancer Reauthorization Act
Client: CHILDREN'S CANCER CAUSE · Firm: CHILDREN'S CANCER CAUSE
Childhood Cancer Research, NCI appropriations, Caroline Pryce Walker Conquer Childhood Cancer Reauthorization Act (H.R.2607/S.1251)
Caroline Pryce Walker Conquer Childhood Cancer Reauthorization Act
Client: CHILDREN'S CANCER CAUSE · Firm: CHILDREN'S CANCER CAUSE
Childhood Cancer research, NCI appropriations, Caroline Pryce Walker Conquer Childhood Cancer Reauthorization Act (H.R.2607/S.1251)
Food and Drug Administration Reform Act of 2012
Client: CHILDREN'S CANCER CAUSE · Firm: CHILDREN'S CANCER CAUSE
Support for language modifications in Best Pharmaceiticals for Children Act and Pediatric Research Equality Act included in H.R.5651 and S.3187.
CAPTA Reauthorization Act of 2010
Client: CHILDREN'S CANCER CAUSE · Firm: CHILDREN'S CANCER CAUSE
Childhood cancer survivorship legislation Language modifications for the Best Pharmaceuticals for Children Act and Pediatric Research Equity Act, as included in S. 3817
Childhood Cancer research, NCI appropriations, Caroline Pryce Walker Conquer Childhood Cancer Reauthorization Act (H.R.2607/S.1251)
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
CHILDREN'S CANCER CAUSE via CHILDREN'S CANCER CAUSE
2014 · first_quarter · Q1
Childhood Cancer research, NCI appropriations, Caroline Pryce Walker Conquer Childhood Cancer Reauthorization Act, Childhood Cancer Survivors Quality of Life Act
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
CHILDREN'S CANCER CAUSE via CHILDREN'S CANCER CAUSE
2013 · fourth_quarter · Q4
Childhood cancer research, NCI appropriations, Caroline Pryce Walker Conquer Childhood Cancer Reauthorization Act, Childhood Cancer Survivors' Quality of Life Act
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
CHILDREN'S CANCER CAUSE via CHILDREN'S CANCER CAUSE
2013 · third_quarter · Q3
Childhood cancer research, NCI funding, appropriations, Caroline Pryce Walker Conquer Childhood Cancer Act, Childhood Cancer Survivors' Quality of Life Act
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
CHILDREN'S CANCER CAUSE via CHILDREN'S CANCER CAUSE
2013 · second_quarter · 2A
Childhood Cancer, Childhood Cancer Survivorship, Caroline Pryce Walker Conquer Childhood Cancer Act, Childhood Cancer Survivors' Quality of Life Act, Patients' Access to Treatments Act, NCI funding, appropriations.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
CHILDREN'S CANCER CAUSE via CHILDREN'S CANCER CAUSE
2013 · second_quarter · Q2
Childhood Cancer, Childhood Cancer Survivorship, Caroline Pryce Walker Conquer Childhood Cancer Act, Childhood Cancer Survivors' Quality of Life Act, Patients' Access to Treatments Act, NCI funding, appropriations
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
CHILDREN'S CANCER CAUSE via CHILDREN'S CANCER CAUSE
2012 · fourth_quarter · Q4
Childhood cancer Affordable Care Act Childhood cancer survivorship Drug development
Filing targets: Centers For Medicare and Medicaid Services (CMS), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Natl Institutes of Health (NIH), SENATE
CHILDREN'S CANCER CAUSE via CHILDREN'S CANCER CAUSE
2012 · third_quarter · Q3
Childhood cancer survivorship legislation Language modifications for the Best Pharmaceuticals for Children Act and Pediatric Research Equity Act, as included in S. 3817
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
CHILDREN'S CANCER CAUSE via CHILDREN'S CANCER CAUSE
2012 · second_quarter · Q2
Support for language modifications in Best Pharmaceiticals for Children Act and Pediatric Research Equality Act included in H.R.5651 and S.3187.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE